2024 Onco-Nephrology Symposium

The 2024 Onco-Nephrology Symposium welcomes all members of the healthcare team who manage patients with both cancer and kidney disease. This year's program embraces the multidisciplinary nature of onco-nephrology and features experts in plasma cell disorders such as multiple myeloma, amyloidosis, monoclonal gammopathies as well as renowned speakers on CAR T cell, other biologic therapies, thrombotic microangiopathy, and cardio-renal syndromes. The goal of this forum is to allow academicians, clinicians, and clinical experts to have personal exchanges and robust discussions in order to enhance the clinical experiences and outcomes of patients.

The target audience for this program includes physicians, advanced practice providers, nurses, medical students, and other healthcare professionals interested in the care of cancer patients with kidney disease. This symposium offers attendees the option to participate either in person at Memorial Sloan Kettering's Zuckerman Research Center (417 East 68th Street, New York City) or virtually via Zoom.

Registered attendees will receive access to an online syllabus after the symposium, which will include select PDFs of the faculty presentations (slides) and recorded videos.

Exclusive Discount Offer

1. Outline a comprehensive assessment and treatment of thrombotic microangiopathy
2. Strategize a treatment plan for the patient with MGRS as part of a multidisciplinary team
3. Effectively utilize novel diagnostic techniques to diagnose monoclonal disorders
4. Recognize renal and non-renal toxicities of modern cancer therapy
5. Formulate an treatment plan for kidney transplant patients who receive CAR T cell therapy
6. Assimilate genetic testing data in the evaluation of thrombotic microangiopathy
7. Review assessment and management of glomerular disorders in cancer patients
8. Apprehend modern therapeutic approaches to small renal masses and cancers of the kidney

This symposium offers participants the choice of attending either in person or virtually. In-person registrants will be provided continental breakfast, lunch, and refreshment breaks. Please contact [email protected] at least one week prior to the course if you have any special dietary requests or require any specific accommodations for joining us onsite.

Discounted registration is available for specific groups. If eligible, you will receive further instructions and a promotion code to use during registration. View our Policy on Registration Discounts for more information.

Registration Fees

• Physicians (MDs, PhDs, and DOs): $450
• Advanced Practice Providers: $350
• Residents, Fellows, Nurses, and Other Healthcare Providers: $250
• Industry Professionals*: $750
• MSK Employees: Complimentary

For details on our cancellation terms, please review our Cancellation Policy.

*An “industry professional” is defined as any individual, regardless of their profession type (such as MDs, PhDs, APPs, RNs, etc.) that is employed by an ineligible company. View our Registration Policy for Industry Professionals for more information.

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 11.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC/CC Recognition Statements

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:

• 11.00 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program; and
• 11.00 Lifelong Learning (CME) credits in the American Board of Pathology’s (ABPath) Continuing Certification program.

It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM or ABPath MOC/CC credit.

Memorial Sloan Kettering Cancer Center–Nursing Professional Development / Continuing Education is accredited with distinction as a provider of nursing continuing professional development (NCPD) by the American Nurses Credentialing Center’s Commission on Accreditation.

11.25 contact hours will be awarded to participants who attend the program in its entirety and complete a program evaluation. Partial credit not awarded.

Hotel Accommodations

We look forward to welcoming you to Memorial Sloan Kettering for this program. If you’ll be traveling to New York City from out of town, we recommend that you plan your overnight stays as soon as possible. To make the planning a little easier, Memorial Sloan Kettering has negotiated special rates and amenities at select hotels in Manhattan. To view the list of select hotels and additional details on each, please visit: msk.org/accommodations

Parking Information

Street parking in Manhattan is extremely limited, so you may find it more convenient to park in Memorial Sloan Kettering’s garage or in a commercial garage. For a list of parking resources around MSK, click here. Please note that MSK CME does not offer parking validation for course attendees.

MSK Course Directors 

Sheron Latcha, MD
Program Director, Nephrology Fellowship;
Attending, Renal Service, 
Department of Medicine 

Aisha Shaikh, MBBS
Associate Attending, Renal Service 
Department of Medicine 

Invited Symposium Faculty 

Ala Abudayyeh, MD
Director, of Clinical Research, Division Section of Nephrology
MD Anderson Cancer Center
Houston, TX, USA

Pooja Amarapurkar MD 
Director of Onco-Nephrology;
Assistant Professor of Medicine, 
Renal and Electrolyte Division 
University of Pittsburgh School of Medicine 
University of Pittsburgh Medical Center 
Pittsburgh, PA, USA

Chris Blosser, MD
Professor of Medicine; 
Director, Fred Hutch Cancer and Organ Transplant Clinic;
Director, Center for Innovations in Cancer and Transplant,
University of Washington; 
Seattle Children’s Hospital;
Fred Hutch Cancer Center
Seattle, Washington, USA

Sandra Herrmann, MD
Professor of Medicine 
Mayo Clinic
Rochester, MN, USA

Kenar Jhaveri, MD 
Professor of Medicine;
Co-Director Onco-Nephrology Services
Donald and  Barbara Zucker School of Medicine at Hofstra / Northwell 
New York, NY, USA

Sabine Karam, MD 
Assistant Professor of Medicine
University of Minnesota
Minneapolis, MN, USA

David Kavanagh, PhD
Professor of Complement Therapeutic at National Renal Complement Therapeutics Centre,
Freeman Hospital Renal Center
Newcastle Upon Tyne, England, UK

Abhijat Kitchlu MD, MSc
Staff Nephrologist; Clinician Investigator,
University Health Network;
Associate Professor of Medicine,
University of Toronto
Toronto, ON, Canada

Nelson Leung, MD
Professor of Medicine; 
Program Director, Onco-Nephrology Fellowship
Mayo Clinic
Rochester, MN, USA

Syed Saad Mahmood, MD, MPH
System Director, Cardio-Oncology 
St. Francis Hospital & Heart Center 
Roslyn, NY, USA

Glen Markowitz, MD
Professor of Pathology and Cell Biology;
Executive Vice Chair for Anatomic Pathology
Columbia University Irving Medical Center
New York, NY, USA

Samih Nasr, MD
Professor of Laboratory Medicine and Pathology 
Mayo Clinic
Rochester, MN, USA

Carla Nester, MD, MSA, FASN
Associate Director, Molecular Otolaryngology and Renal Research Laboratories;
Director, Pediatric Glomerular Disease Clinic;
Director, Rare Disease Clinic 
University of Iowa Hospitals and Clinics
Iowa City, IA, USA

Arash Rashidi, MD
Clinical Associate Professor; 
Director, Onco-Nephrology Program
University Hospitals Cleveland Medical Center
Cleveland, OH, USA

Steven Salvatore, MD
Associate Professor of Clinical Pathology and Laboratory Medicine 
Weill Cornell Medicine
New York, NY, USA

Biruh Workaneh, MD
Professor of Medicine
MD Anderson Cancer Center
Houston, TX, USA

MSK Symposium Faculty

Lisa Bodei, MD, PhD
Director, Radiopharmaceutical Therapy Section; 
Attending, Molecular Imaging and Therapy Service,
Department of Radiology

Jessica Chapman, PhD
Director, Clinical Proteomics;
Assistant Attending, Hematopathology Service,
Department of  Pathology and Laboratory Medicine

Sherrilyn Eudoxie, RN
Clinical Nurse

James Flory, MD
Associate Attending, Endocrinology Service,
Department of Medicine;
Associate Professor of Medicine

Samuel Funt, MD
Assistant Attending, Genitoruinary Oncology Service,
Department of Medicine;
Assistant Professor of Medicine 

Ilya Glezerman, MD
Attending; Clinical Director, Renal Service
Department of Medicine 

Victoria Gutgarts, MD
Assistant Attending, Renal Service,
Department of Medicine;
Assistant Professor of Medicine

Ari Hakimi, MD
Associate Attending, Urology Service,
Department of Surgery; 
Associate Professor of Surgery

Hamza Hashimi, MD
Assistant Attending, Myeloma Service,
Department of Medicine

Hani Hassoun, MD
Attending, Myeloma Service,
Department of Medicine;
Professor of Medicine

Malin Hulcrantz, MD
Associate Attending, Myeloma Service,
Department of Medicine;
Associate Professor of Medicine

Insara Jaffer Sathick, MBBS
Assistant Attending, Renal Service,
Department of Medicine;
Assistant Professor of Medicine

Edgar Jaimes, MD
Chief, Renal Service,
Department of Medicine;
Professor of Medicine

Heather Landau, MD
Director, Amyloidosis Program; 
Associate Attending, Bone Marrow Transplant and Cellular Therapy Services,
Department of Medicine

Jennifer Liu, MD, FACC
Chief, Cardiology Service;
Director Cardiovascular Laboratories
Department of Medicine

Monica Maguire, RN
Clinical Nurse

Sham Mailankody, MBBS
Associate Attending; Clinical Director, Cellular Therapy Service; 
Research Director, Myeloma Service,
Department of Medicine
Associate Professor of Medicine

Kazunori Murata, PhD
Director, Ralph Lauren Center Laboratory

Karlo Perica, MD
Assistant Attending, Immunology Program,
Sloan Kettering Institute;
Assistant Professor of Medicine

Michael Scordo, MD
Assistant Attending, Bone Marrow Transplant and Cellular Therapy Services, 
Department of Medicine 

Saad Usmani, MD
Chief, Myeloma Service,
Department of Medicine 

Martin Voss, MD
Associate Attending; Clinical Director, 
Genitourinary Medical Oncology Service,
Department of Medicine;
Associate Professor of Medicine 

Mitigation of Relevant Financial Relationships

Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Sheron Latcha, MD
MSK

Activity Co-Director, Conflict of Interest Peer Reviewer, Faculty

Nothing to disclose

Aisha Shaikh, MBBS
MSK
Usa

Activity Co-Director, Conflict of Interest Peer Reviewer, Faculty

Nothing to disclose

Ala Abudayyeh, MD
MD Anderson Cancer Center

Faculty

Nothing to disclose

Christopher Blosser, MD
UW Medicine
Usa

Faculty

Advisor-Natera, LLC (Relationship has ended)|Advisor-CareDx Inc (Relationship has ended)

Lisa Bodei, MD
MSK

Faculty

Grant or research support-Novartis AG

Jessica Chapman, PhD
MSK

Faculty

Honoraria-Covaris

James Flory , MD
MSK

Faculty

Nothing to disclose

Samuel A. Funt, MD
MSK

Faculty

Consulting Fee-Merck and Company, Inc.|Grant or research support-ALX Oncology|Consulting Fee-Generate:Biomedicines|Stocks or stock options, excluding diversified mutual funds-Doximity|Grant or research support-Decibel (Relationship has ended)|Grant or research support-AstraZeneca|Grant or research support-Genentech, Inc.|Stocks or stock options, excluding diversified mutual funds-Allogene Therapeutics |Stocks or stock options, excluding diversified mutual funds-Urogen|Stocks or stock options, excluding diversified mutual funds-Kronos Bio|Stocks or stock options, excluding diversified mutual funds-Neogene Therapeutics (Relationship has ended)|Stocks or stock options, excluding diversified mutual funds-IconOVir|Stocks or stock options, excluding diversified mutual funds-Vida Ventures

Ilya Glezerman, MD
MSK

Faculty

Consulting Fee-T-Knife Inc.

Victoria Gutgarts, MD
MSK

Faculty

Nothing to disclose

Abraham A Hakimi, MD
MSK

Faculty

Grant or research support-Merck and Company, Inc.

Hamza Hashimi, MD
MSK

Faculty

Consulting Fee-Johnson and Johnson (Relationship has ended)|Honoraria-AMGEN (Relationship has ended)

Hani Hassoun, MD
MSK
Usa

Faculty

Nothing to disclose

Sandra Herrmann, MD
Mayo Clinic

Faculty

Nothing to disclose

Malin Hultcrantz, MD, PhD
MSK

Faculty

Grant or research support-GlaxoSmithKline|Advisor-GlaxoSmithKline|Grant or research support-Daiichi Sankyo|Advisor-Bristol-Myers Squibb|Grant or research support-Beigene|Advisor-Johnson and Johnson (Relationship has ended)|Grant or research support-Abbvie|Grant or research support-Cosette Pharmaceuticals

Insara Jaffer, MBBS
MSK
Usa

Faculty

Nothing to disclose

Edgar Jaimes, MD
MSK
Usa

Faculty

Nothing to disclose

Kenar D Jhaveri, MD
Northwell
Usa

Faculty

Consulting Fee-GlaxoSmithKline (Relationship has ended)|Consulting Fee-Calliditas|Consulting Fee-George Clinicals|Consulting Fee-PMV|Honoraria-American Society of Nephrology|Honoraria-Lexicomp|Honoraria-Uptodate.com|Consulting Fee-Decipher|Consulting Fee-Citrus Oncology|Consulting Fee-Otsuka

Sabine Karam , MD
University of Minnesota
Usa

Faculty

Nothing to disclose

David Kavanagh, MD, PhD, Professor of Complement Therapeutics
Newcastle University
United Kingdom

Faculty

Advisor-Novartis AG|Advisor-AstraZeneca

Abhijat Kitchlu, MD, MS, FRCPC
University of Toronto
Canada

Faculty

Other: Onco-Nephrology Fellowship Funding Support-Amgen|Other: Onco-Nephrology Fellowship Funding Support-Janssen

Heather J Landau, MD
MSK
Usa

Faculty

Advisor-Janssen Scientific Affairs, LLC (Relationship has ended)|Grant or research support-Protego|Advisor-Pfizer, Inc. (Relationship has ended)|Advisor-Prothena|Grant or research support-Prothena|Grant or research support-Alexion Pharmaceuticals|Grant or research support-Takeda Pharmaceuticals, Inc. (Relationship has ended)|Grant or research support-Janssen Scientific Affairs, LLC|Advisor-Nexcella|Grant or research support-Nexcella

Nelson Leung, MD
Mayo
Usa

Faculty

Stocks or stock options, excluding diversified mutual funds-Abbvie|Stocks or stock options, excluding diversified mutual funds-Checkpoint Therapeutics

Jennifer Liu, MD
MSK

Faculty

Review Panel Member-Caelum Biosciences|Honoraria-GE Healthcare Bio-Sciences (Relationship has ended)|Honoraria-Philips Medical Systems, Inc. (Relationship has ended)|Grant or research support-Johnson and Johnson

Sayed Mahmood, MD, MPH
Catholic Health

Faculty

Consulting Fee-Abbot (Relationship has ended)|Consulting Fee-Altathera (Relationship has ended)

Sham Mailankody, MD
MSK
Usa

Faculty

Grant or research support-Johnson and Johnson|Grant or research support-Bristol-Myers Squibb|Grant or research support-Takeda Pharmaceuticals, Inc. (Relationship has ended)|Grant or research support-Allogene Therapeutics|Grant or research support-Fate Therapeutics|Consulting Fee-Johnson and Johnson (Relationship has ended)|Review Panel Member-Abbvie|Consulting Fee-Legend Biotech (Relationship has ended)|Advisor-Optum|Consulting Fee-Evicore (Relationship has ended)|Honoraria-MJH life Sciences (Relationship has ended)|Honoraria-Physician Education Resource (Relationship has ended)|Consulting Fee-Bristol-Myers Squibb (Relationship has ended)|Review Panel Member-ArcellX

Glen Markowitz, MD, Professor of Pathology & Cell Biology
Columbia University Irving Medical Center

Faculty

Nothing to disclose

Kazunori Murata, PhD
MSK

Faculty

Grant or research support-Abbott Laboratories (Relationship has ended)|Grant or research support-Siemens Healthineers|Grant or research support-Sebia USA|Grant or research support-The Binding Site

Samih Nasr, MD, Professor
Mayo Clinic
Usa

Faculty

Nothing to disclose

Carla M Nester, MD, MS
University of Iowa Hospitals and Clinics

Faculty

Grant or research support-Novartis AG|Grant or research support-Apellis|Grant or research support-Biocryst (Relationship has ended)|Advisor-AstraZeneca|Advisor-Kira (Relationship has ended)|Grant or research support-Retrophen (Relationship has ended)

Karlo Perica, MD
MSK

Faculty

Royalties or Patent Beneficiary-Neximmune Inc

Arash Rashidi, MD
University Hospitals Cleveland Medical Center

Faculty

Speakers Bureau-AstraZeneca|Speakers Bureau-Otsuka America Pharmaceutical, Inc.|Speakers Bureau-Bayer Corporation

Steven Salvatore, MD
Weill Cornell Medicine
Usa

Faculty

Nothing to disclose

Michael Scordo, MD
MSK

Faculty

Consulting Fee-Omeros Corporation (Relationship has ended)|Grant or research support-Omeros Corporation (Relationship has ended)|Grant or research support-Amgen, Inc. (Relationship has ended)|Consulting Fee-Kite - A Gilead Company (Relationship has ended)|Grant or research support-Angiocrine Bioscience, Inc.|Consulting Fee-Angiocrine Bioscience, Inc. (Relationship has ended)|Grant or research support-Sanofi-Aventis|Grant or research support-Bristol-Myers Squibb (Relationship has ended)|Advisor-Miltenyi Biotec (Relationship has ended)

Saad Usmani, MD
MSK

Faculty

Advisor-Abbvie|Grant or research support-Abbvie|Advisor-Amgen (Relationship has ended)|Speakers Bureau-Amgen (Relationship has ended)|Grant or research support-Amgen (Relationship has ended)|Advisor-Bristol-Myers Squibb|Grant or research support-Bristol-Myers Squibb|Speakers Bureau-Bristol-Myers Squibb (Relationship has ended)|Advisor-Johnson and Johnson|Grant or research support-Johnson and Johnson|Honoraria-Johnson and Johnson (Relationship has ended)|Advisor-Sanofi-Aventis (Relationship has ended)|Grant or research support-Sanofi-Aventis (Relationship has ended)|Speakers Bureau-Sanofi-Aventis (Relationship has ended)|Advisor-Gilead (Relationship has ended)|Advisor-Genentech, Inc. (Relationship has ended)|Advisor-Oncopeptides (Relationship has ended)|Honoraria-Oncopeptides (Relationship has ended)|Grant or research support-Takeda Pharmaceuticals, Inc. (Relationship has ended)|Consulting Fee-Takeda Pharmaceuticals, Inc. (Relationship has ended)|Advisor-Teneobio (Relationship has ended)|Advisor-GlaxoSmithKline|Grant or research support-GlaxoSmithKline (Relationship has ended)|Advisor-SecuraBio (Relationship has ended)|Grant or research support-Merck and Company, Inc. (Relationship has ended)

Martin H Voss, MD
MSK

Faculty

Honoraria-Ideology Health (Relationship has ended)|Honoraria-Cancer Network (Relationship has ended)|Honoraria-Multi Media Medical (Relationship has ended)|Honoraria-MedNet (Relationship has ended)|Honoraria-TalemHealth (Relationship has ended)|Honoraria-OncLive (Relationship has ended)|Honoraria-Axiom (Relationship has ended)|Honoraria-Targeted Oncology (Relationship has ended)|Honoraria-Mashup Media (Relationship has ended)|Advisor-Eisai, Inc. (Relationship has ended)|Advisor-Exelixis (Relationship has ended)|Advisor-Merck and Company, Inc.|Advisor-Aveo Oncology|Advisor-Genentech, Inc. (Relationship has ended)|Advisor-Oncorena|Advisor-Affimed|Grant or research support-AstraZeneca|Grant or research support-BMS (Relationship has ended)|Grant or research support-Calithera (Relationship has ended)|Grant or research support-Pfizer, Inc. (Relationship has ended)|Grant or research support-Merck and Company, Inc.|Grant or research support-Genentech, Inc. (Relationship has ended)|Grant or research support-Roche (Relationship has ended)|Grant or research support-NiKang Therapeutics|Advisor-Affimed|Advisor-Aravive (Relationship has ended)|Advisor-onQuality (Relationship has ended)|Advisor-Immunitybio (Relationship has ended)|Advisor-AstraZeneca|Advisor-Mertelsmann Foundation|Advisor-Genentech, Inc. (Relationship has ended)|Advisor-Merck and Company, Inc.|Advisor-Nikang Therapeutics

Biruh T Workaneh, MD, FASN
MD Anderson Cancer Center

Faculty

Honoraria-Otsuka America Pharmaceutical, Inc.

sherrilyn eudoxie, rn
MSK

Faculty, Nurse Content Expert

Nothing to disclose

Monica Maguire, BSN
MSK

Faculty, Nurse Content Expert

Nothing to disclose

Meagan McQuade, MSN, BSN
MSKCC

Nurse Planner

Nothing to disclose

Memorial Sloan Kettering Cancer Center gratefully acknowledges the following organization for providing a medical education grant this live activity:
Omeros

Memorial Sloan Kettering is pleased to announce that the following company will be exhibiting during this symposium: 

BioPorto Diagnostics Inc.
Eisai
Johnson & Johnson
Merck
Novartis Pharmaceuticals, Inc.
Pfizer Oncology
Sanofi
Serb Pharmaceuticals